Equities

Dishman Carbogen Amcis Ltd

Dishman Carbogen Amcis Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)191.29
  • Today's Change7.59 / 4.13%
  • Shares traded863.04k
  • 1 Year change+23.41%
  • Beta1.8393
Data delayed at least 15 minutes, as of Sep 20 2024 11:28 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income(1223)(546)(43)
Depreciation/depletion3,1092,8073,076
Non-Cash items1,1981,637280
Cash taxes paid, supplemental190342563
Cash interest paid, supplemental986733598
Changes in working capital756(1239)235
Total cash from operations3,8402,6603,549
INVESTING
Capital expenditures(3033)(6197)(4638)
Other investing and cash flow items, total7371,256(1547)
Total cash from investing(2295)(4941)(6185)
FINANCING
Financing cash flow items(986)(733)(598)
Total cash dividends paid------
Issuance (retirement) of stock, net----0
Issuance (retirement) of debt, net7653,2301,902
Total cash from financing(222)2,4971,304
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash1,323215(1333)
Net cash-begin balance/reserved for future use1,3181,1022,435
Net cash-end balance/reserved for future use2,6411,3181,102
SUPPLEMENTAL INCOME
Depreciation, supplemental3,1092,8073,076
Cash interest paid, supplemental986733598
Cash taxes paid, supplemental190342563
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.